Hepatoblastoma diagnosed in infancy occurring in single-ventricle patients: a case series

McAllister O Windom1, M Jay Campbell1

  • 1Department of Pediatric Cardiology, Duke University Medical Center, Durham, NC27710, USA.

Cardiology in the Young
|September 30, 2020
PubMed

Insights

Hepatoblastoma, a common childhood liver tumor, has not been documented in single-ventricle congenital heart disease patients. This report details three unique cases, marking the first known instances in this population.

Area of Science:

  • Pediatric oncology
  • Congenital heart disease
  • Hepatobiliary medicine

Background:

  • Hepatoblastoma is the most frequent primary liver tumor in pediatric populations.
  • There is a lack of reported cases of hepatoblastoma within the single-ventricle congenital heart disease (SV-CHD) demographic.
  • Single-ventricle physiology presents unique challenges in pediatric care.

Purpose of the Study:

  • To report the first documented cases of hepatoblastoma in patients with single-ventricle congenital heart disease.
  • To highlight the occurrence of hepatoblastoma in a population previously considered unaffected.
  • To raise awareness among clinicians managing SV-CHD patients about this potential comorbidity.

Main Methods:

  • Retrospective case series.
  • Review of medical records for three pediatric patients diagnosed with hepatoblastoma.
  • Analysis of patient demographics, clinical presentation, and diagnostic timelines, specifically noting the stage relative to Fontan completion.

Main Results:

  • Three cases of hepatoblastoma were identified in patients with single-ventricle congenital heart disease.
  • The mean age at diagnosis was 19.7 months (±4 months).
  • Hepatoblastoma diagnosis occurred before Fontan procedure completion in all three patients.

Conclusions:

  • This study presents the only documented instances of hepatoblastoma in patients with single-ventricle congenital heart disease.
  • The findings suggest a potential, albeit rare, association between SV-CHD and hepatoblastoma.
  • Further research is warranted to explore potential underlying mechanisms and clinical implications for this specific patient group.

Related Concept Videos